Fulcrum Therapeutics reports promising late-stage data for sickle cell drug pociredir, with notable hemoglobin improvements.

A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...

A drug from Fulcrum Therapeutics showed promise in a sickle cell study, raising the possibility that a pill could be an ...

The National Sickle Cell Summit 2025 brought together a powerful cross-section of voices, including survivors, healthcare providers, scientists, patient advocacy groups, and senior policymakers, with ...

Orville Johnson said he wanted Justin, 16, to try to have a normal life despite his sickle cell disease. Now he has to walk by his son's empty bedroom. "I loved him so much." ...

Chimeric antigen receptor (CAR) T-cell therapy has shown impressive efficacy in treating relapsed or refractory multiple myeloma. Nonetheless, its availability is substantially restricted by complex ...

Sickle cell disease can lead to a severe complication known as acute chest syndrome (ACS), but the underlying mechanisms are not well understood.

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

A Kennesaw State University student is working to develop a low-cost tool to screen for stroke in children with sickle cell disease. Sickle cell is a genetic disorder that affects more than 300,000 ...

As a medical professional living with sickle cell anemia, I’ve chosen to dedicate myself to sickle cell advocacy and education. On this journey, I’ve realized a lot of people cannot distinguish ...

33 states pick up CMS program to pay for sickle cell gene therapies States representing about 84% of Medicaid beneficiaries have signed onto an initiative that could broaden access to therapies ...

We reviewed the evidence to see if regular long-term red blood cell transfusions helped to reduce the occurrence or progression of chronic chest complications compared to hydroxycarbamide (hydroxyurea ...